Cite Filings / DSGN / 0001104659-22-129507
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G

Amended Statement of Ownership

Design Therapeutics, Inc. · Filed 2022-12-22 · Acc 0001104659-22-129507

Documents 1

  • SC 13G Amended Statement of Ownership , tm2233370d1_sc13g.htm

Around this filing

  • 2023-02-03 SC 13G Amended Statement of Ownership
  • 2022-12-22 SC 13D/A Beneficial Ownership Report
  • 2022-12-22 SC 13G Amended Statement of Ownership
  • 2022-12-21 4 President and CEO bought 7,450 shares at an average $8.39 ($62,503)
  • 2022-12-20 4 Director bought 900,000 shares at an average $8.42 ($7,574,078)
  • 2022-12-20 4 10% owner bought 900,000 shares at an average $8.42 ($7,574,078)
  • 2022-10-13 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading tm2233370d1_sc13g.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…